Dong-A University Hospital

Busan, Korea, Republic of
Hospital in Busan
26 Daesingongwon-ro, Seo-gu, Busan
992 Beds

About Dong-A University Hospital


Dong-A University Hospital is a major general hospital affiliated with Dong-A University in Busan, South Korea. The hospital is situated in the Seo-gu area of Busan, within 20 minutes of Dong-A University's Seunghak and Bumin campuses.
There are 992 beds in Dong-A University Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
15
Hoffmann-La Roche
13
Chong Kun Dang Pharmaceutical
12
Dong-A University
12
Seung-Jung Park
12
Boehringer Ingelheim
9
Eli Lilly and Company
7
Celgene
6
Gilead Sciences
6
Inha University Hospital
5
Janssen Research & Development, LLC
5
Total Rows: 100

Clinical Trials at Dong-A University Hospital


During the past decade, Dong-A University Hospital conducted 160 clinical trials. In the 10-year time frame, 160 clinical trials started and 59 clinical trials were completed, i.e. on average, 36.9% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 37 clinical trials were completed. i.e. 80.4% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years131322222828262625251414191913130044444410101111991313Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction
2001-03-01
2006-02-01
Completed
270
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
2007-05-01
2015-03-01
Completed
520
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma
2006-01-01
2007-08-01
Completed
14
The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients
2009-07-01
2010-07-01
Unknown status
70
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV
2012-03-02
2016-05-20
Completed
244
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
2009-12-01
2012-04-01
Terminated
446
Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer
2009-06-01
2011-05-01
Completed
22

Rows per page:

1–100 of 243

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Dong-A University Hospital" #1 sponsor was "Pfizer" with 15 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "Chong Kun Dang Pharmaceutical" with 12 trials sponsored, "Dong-A University" with 12 trials sponsored and "Seung-Jung Park" with 12 trials sponsored. Other sponsors include 174 different institutions and companies that sponsored additional 109 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dong-A University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 18 trials as a collaborator, "Eli Lilly and Company" with 8 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Dong-A University Hospital" with 4 trials as a collaborator and "Coalition for Epidemic Preparedness Innovations" with 3 trials as a collaborator. Other collaborators include 115 different institutions and companies that were collaborators in the rest 101 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 15Pfizer: 15Hoffmann-La Roche: 13Hoffmann-La Roche: 13Chong Kun DangPharmaceutical: 12Chong Kun DangPharmaceutical: 12Dong-A University: 12Dong-A University: 12Seung-Jung Park: 12Seung-Jung Park: 12Boehringer Ingelheim: 9Boehringer Ingelheim: 9Eli Lilly and Company: 7Eli Lilly and Company: 7Celgene: 6Celgene: 6Gilead Sciences: 6Gilead Sciences: 6Inha University Hospital: 5Inha University Hospital: 5

Created with Highcharts 11.1.0Top CollaboratorsCardioVascularResearch Foundation,Korea: 18CardioVascularResearch Foundation,Korea: 18Eli Lilly and Company: 8Eli Lilly and Company: 8Merck KGaA,Darmstadt, Germany: 5Merck KGaA,Darmstadt, Germany: 5Dong-A University Hospital: 4Dong-A University Hospital: 4Coalition for EpidemicPreparednessInnovations: 3Coalition for EpidemicPreparednessInnovations: 3Korea University: 3Korea University: 3Korean Cancer Study Group: 3Korean Cancer Study Group: 3Kyungpook NationalUniversity Hospital: 3Kyungpook NationalUniversity Hospital: 3AbbVie: 2AbbVie: 2Academic andCommunity CancerResearch United: 2Academic andCommunity CancerResearch United: 2

Clinical Trials Conditions at Dong-A University Hospital


According to Clinical.Site data, the most researched conditions in "Dong-A University Hospital" are "Coronary Artery Disease" (16 trials), "Alzheimer's Disease" (10 trials), "Gastric Cancer" (10 trials), "Ulcerative Colitis" (9 trials) and "Crohn Disease" (6 trials). Many other conditions were trialed in "Dong-A University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Dong-A University Hospital


Most popular intervention types in "Dong-A University Hospital" are "Drug" (191 trials), "Other" (20 trials), "Biological" (17 trials), "Device" (16 trials) and "Procedure" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (49 trials), "Oxaliplatin" (7 trials), "Capecitabine" (5 trials), "Etrasimod" (4 trials) and "Etrolizumab" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Dong-A University Hospital


The vast majority of trials in "Dong-A University Hospital" are 232 trials for "All" genders, 8 trials for "Male" genders and 2 trials for "Female" genders.

Clinical Trials Status at Dong-A University Hospital


Currently, there are NaN active trials in "Dong-A University Hospital". undefined are not yet recruiting, 47 are recruiting, 28 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 107 completed trials in Dong-A University Hospital, undefined suspended trials, and 30 terminated clinical trials to date.
Out of the total trials that were conducted in Dong-A University Hospital, 18 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 13 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 98Phase 3: 98Phase 2: 54Phase 2: 54Phase 4: 33Phase 4: 33Phase 1: 18Phase 1: 18Not Applicable: 13Not Applicable: 13

Created with Highcharts 11.1.0Trials StatusCompleted: 107Completed: 107Recruiting: 47Recruiting: 47Terminated: 30Terminated: 30Unknown status: 29Unknown status: 29Active, not recruiting: 28Active, not recruiting: 28Enrolling by invitation: 1Enrolling by invitation: 1Withdrawn: 1Withdrawn: 1